About MMS Holdings
MMS Holdings (MMS) is an innovative, data-focused CRO that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, MMS maintains a 97 percent customer satisfaction rating. MMS colleagues are working on multiple rare disease projects, and the company offers a pro-bono rare disease initiative for patient advocacy groups. For Rare Disease Day, MMS is changing our social media logo to pink, green, and blue to show our colors and will share facts about rare disease and why our colleagues think rare disease work is important on social media.